Meeting
2016 ASCO Annual Meeting
Phase II study of intraperitoneal paclitaxel plus S-1/oxaliplatin for gastric cancer with peritoneal metastasis: SOX+IP PTX trial.
Authors
Yoshiyuki Fujiwara
Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan
Yoshiyuki Fujiwara , Hironori Ishigami , Hiroto Miwa , Tsutomu Tanaka , Yasuhiro Kodera , Haruhiko Imamoto , Motohiro Imano , Ryoji Fukushima , Akio Hidemura , Shugo Ueda , Atsushi Nashimoto , Hiroshi Yabusaki , Tetsuya Kusumoto , Yoshikazu Uenosono , Hiroharu Yamashita , Hironori Yamaguchi , Toshiaki Watanabe , Joji Kitayama
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer
Clinical Trial Registration Number
UMIN000012834
Citation
J Clin Oncol 34, 2016 (suppl; abstr 4040)
DOI
10.1200/JCO.2016.34.15_suppl.4040
Abstract #
4040
Poster Bd #
32
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Phase II study of intraperitoneal paclitaxel combined with S-1 plus cisplatin for gastric cancer with peritoneal metastasis: SP + IP PTX trial.
First Author: Daisuke Kobayashi
Poster
2017 ASCO Annual Meeting
Phase II study of intraperitoneal docetaxel plus capecitabine/cisplatin for gastric cancer with peritoneal metastasis: XP+IP DOC trial.
First Author: Ryoji Fukushima
Poster
2022 ASCO Genitourinary Cancers Symposium
GAMMA: Results from a phase II study for relapsed germ cell tumors using an oxaliplatin-based treatment regimen.
First Author: Kenrick Ng
Poster
2018 Gastrointestinal Cancers Symposium
Intraperitoneal chemotherapy for gastric cancer with peritoneal dissemination: A single center retrospective analysis of 82 cases.
First Author: Masahiro Yoshida